WallStreetZenWallStreetZen

NASDAQ: DRMA
Dermata Therapeutics Inc Stock Ownership - Who owns Dermata Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dermata Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Munera Maria E. BedoyatoroSVP Regulatory Affairs2026-02-171,000$1.27
$1.27kBuy

1 of 1

DRMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DRMA insiders and whales buy or sell their stock.

DRMA Shareholders

What type of owners hold Dermata Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Proehl Investment Ventures LLC72.24%2,905,544$3.46MInsider
Gerald T. Proehl17.22%692,647$824.25kInsider
David F. Hale8.66%348,298$414.47kInsider
Mary Fisher4.90%196,946$234.37kInsider
Hoose Kyri K. Van3.24%130,423$155.20kInsider
Munera Maria E. Bedoyatoro2.12%85,189$101.37kInsider
Wendell Wierenga1.55%62,398$74.25kInsider
Geode Capital Management LLC1.20%48,334$57.52kInstitution
Ubs Group Ag0.89%35,608$42.37kInstitution
Kathleen D. Scott0.74%29,584$35.20kInsider

1 of 2

DRMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DRMA2.29%97.71%Net Buying
BRTX0.66%99.34%Net Buying
MBIO6.70%13.37%Net SellingNet Selling
CDIO3.51%96.49%
PULM4.62%95.38%
View Top Biotech Stocks

Dermata Therapeutics Stock Ownership FAQ

Who owns Dermata Therapeutics?

Dermata Therapeutics (NASDAQ: DRMA) is owned by 2.65% institutional shareholders, 112.89% Dermata Therapeutics insiders, and 0.00% retail investors. Proehl Investment Ventures LLC is the largest individual Dermata Therapeutics shareholder, owning 2.91M shares representing 72.24% of the company. Proehl Investment Ventures LLC's Dermata Therapeutics shares are currently valued at $3.46M.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.